222 related articles for article (PubMed ID: 30687305)
1. Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality.
Rai S; Espinoza JL; Morita Y; Tanaka H; Matsumura I
Front Immunol; 2018; 9():3031. PubMed ID: 30687305
[TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndrome with der (1;7)(q10;p10) complicated with eosinophilia and organizing pneumonia].
Komura A; Meguri Y; Matsubara C; Fujiwara H; Yukawa R; Hayashino K; Nakamura M; Yoshida C; Yamamoto K; Matsuoka KI; Fujii N; Maeda Y; Imajo K
Rinsho Ketsueki; 2023; 64(7):619-625. PubMed ID: 37544721
[TBL] [Abstract][Full Text] [Related]
3. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
[TBL] [Abstract][Full Text] [Related]
4. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia.
Matsushima T; Handa H; Yokohama A; Nagasaki J; Koiso H; Kin Y; Tanaka Y; Sakura T; Tsukamoto N; Karasawa M; Itoh K; Hirabayashi H; Sawamura M; Shinonome S; Shimano S; Miyawaki S; Nojima Y; Murakami H
Blood; 2003 May; 101(9):3386-90. PubMed ID: 12506028
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome with clonal eosinophilia accompanied by eosinophilic pulmonary interstitial infiltration.
Kuroda J; Kimura S; Akaogi T; Hayashi H; Yamano T; Sasai Y; Horiike S; Taniwaki M; Abe T; Kobayashi Y; Kondo M
Acta Haematol; 2000; 104(2-3):119-23. PubMed ID: 11154987
[TBL] [Abstract][Full Text] [Related]
7. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
8. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndrome with eosinophilia in bone marrow. Gunma Haematology Study Group.
Matsushima T; Murakami H; Sawamura M; Tamura J; Sakura T; Matsumoto M; Hirabayashi H; Miyawaki S; Simano S; Sato S
Br J Haematol; 1993 Aug; 84(4):636-8. PubMed ID: 8217821
[TBL] [Abstract][Full Text] [Related]
10. Concurrent pernicious anemia and myelodysplastic syndrome.
Drabick JJ; Davis BJ; Byrd JC
Ann Hematol; 2001 Apr; 80(4):243-5. PubMed ID: 11401093
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
12. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features.
Matsushima T; Murakami H; Tsuchiya J
Leuk Lymphoma; 1994 Nov; 15(5-6):491-7. PubMed ID: 7874007
[TBL] [Abstract][Full Text] [Related]
14. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome that progressed to acute myelomonocytic leukemia with eosinophilia showing peculiar chromosomal abnormality: a case report.
Kim SH; Suh C; Choi SJ; Kim JG; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Kim SH; Seo EJ; Chi HS
J Korean Med Sci; 1999 Aug; 14(4):448-50. PubMed ID: 10485627
[TBL] [Abstract][Full Text] [Related]
16. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
Yamamoto K; Okamura A; Katayama Y; Shimoyama M; Matsui T
Leuk Res; 2009 Mar; 33(3):377-83. PubMed ID: 18829109
[TBL] [Abstract][Full Text] [Related]
17. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
